Arzeda is a biotechnology company that specializes in the development of novel enzymes and chemical products through the use of proprietary advanced computational and synthetic biology technologies. The company's mission is to create sustainable solutions for a variety of industries, including pharmaceuticals, agriculture, and chemicals.

Arzeda

Arzeda, The Protein Design Company™, is a synthetic biology company that creates novel proteins, enzymes and specialty chemical products that compete on performance, cost and sustainability. Partnering with Fortune 500 companies, Arzeda has developed a portfolio of enzymes and specialty chemicals for polymers, pharmaceuticals, industrial chemicals and other advanced applications. More information at www.arzeda.com. 


ARPA-E

National Science Foundation

Washington Research Foundation

Sustainable Conversion Ventures

Bioeconomy Capital

OS Fund

Conversion Ventures LLC

Universal Materials Incubator

Casdin Capital

Lewis & Clark AgriFood

Bunge Ventures

Circulate Capital

Conti Ventures

We are excited to be in San Francisco for #JPM2024! Arzeda is looking forward to meeting with our colleagues, partners, and future collaborators.
 
If your company is developing protein-based therapeutics, reach out to our CEO Alexandre Zanghellini  or CBO Ken Barrett to connect at JPM and learn how Arzeda is supercharging therapeutic development through AI-driven protein design.
 
alexandre.zanghellini@arzeda.com
ken.barrett@arzeda.com
issa.benna@arzeda.com

Thank you Heather Clancy  at GreenBiz Group for connecting with Arzeda CEO Alexandre Zanghellini  and Unilever's head of biotech Neil Parry to discuss all the latest innovations we have helped make possible to drive towards a more #sustainable future! Learn all about how we worked with Unilever to identify new #enzymes that can potentially cut ingredients in half in cleaning and laundry products at: https://lnkd.in/euA-Sxp3

Arzeda Chief Business Officer Ken Barrett will be speaking at this year's Alternative Fuels & Chemicals Coalition Conference in Washington D.C. at Track 3, Session 6 on Tuesday, Nov. 14 at 3:30pm EST! He will be discussing the pressing need for #renewablechemicals in the face of climate change and increased plastic pollution, and illustrating how Arzeda's Intelligent Protein Design Technology™ is transforming the way we create these #biobasedmaterials through the power of #AI. Be sure to join his talk to learn all about our technology and how we are driving the industry toward a cleaner and more sustainable future.
 
Learn more: https://lnkd.in/ey-9ETC6 


OpenFold AI Research Consortium has announced the funding of new large-scale protein studies at Professor Gabriel Rocklin's laboratory at Northwestern University! As founding members of the consortium, we are so excited to see how these datasets will further improve #proteindesign. 

Read more: https://lnkd.in/gAfguUAb

Synthetic biology is breaking barriers and bolstering innovation in industries like pharmaceuticals, food science, and agriculture through #proteindesign! Arzeda co-founders Alexandre Zanghellini and David Baker caught up with Steve Rosenbush to discuss how #AI is bringing synthetic biology to commercial markets with the advent of our Intelligent Protein Design Technology™. 

Read the full The Wall Street Journal article at: https://lnkd.in/eUUfvuHm!

Metric
Company Name	Arzeda
Symbol
MSH ID	COM:ARZEDA
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology
Country	US
Stage	Series C
Employee Count	65
Website	arzeda.com
LinkedIn	arzeda-corp
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	2.79K
Web Traffic Growth	-0.15
Valuation
Raised Capital	38M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	92.78
28-Day Growth Score	20.06
90-Day Growth Score	38.97
365-Day Growth Score	26.69

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:ARZEDA

Arzeda

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue